☆ 4.7 Meeting Abstract

SAFETY PROFILE OF BARICITINIB IN PATIENTS WITH ACTIVE RA: AN INTEGRATED ANALYSIS

ANNALS OF THE RHEUMATIC DISEASES (2016)

Journal

ANNALS OF THE RHEUMATIC DISEASES

Volume 75, Issue -, Pages 243-244

Publisher

BMJ PUBLISHING GROUP

DOI: 10.1136/annrheumdis-2016-eular.1612

Keywords

Funding

AbbVie
Janssen
Eli Lilly and Company
MSD
Pfizer
Roche
Astellas
Galapagos
Vertex
Chugai Pharmaceutical Co,. Ltd
BMS

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

SAFETY PROFILE OF BARICITINIB IN PATIENTS WITH ACTIVE RA: AN INTEGRATED ANALYSIS

Journal

ANNALS OF THE RHEUMATIC DISEASES

Publisher

BMJ PUBLISHING GROUP

Keywords

Categories

Funding

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

SAFETY PROFILE OF BARICITINIB IN PATIENTS WITH ACTIVE RA: AN INTEGRATED ANALYSIS

Journal

ANNALS OF THE RHEUMATIC DISEASES

Publisher

BMJ PUBLISHING GROUP

Keywords

Categories

Funding

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

Export Citation

Share Paper